Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04659629
Title NL-201 in Patients With Relapsed or Refractory Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Neoleukin Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.